Timothy P Noyes is CHIEF EXECUTIVE OFFICER of Aerovate Therapeutics, Inc.. Currently has a direct ownership of 0 shares of AVTE, which is worth approximately $0. The most recent transaction as insider was on Jan 03, 2023, when has been sold 15,000 shares (Common Stock) at a price of $2.14 per share, resulting in proceeds of $32,100. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

TIMOTHY P NOYES Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 03 2023
BUY
Exercise of conversion of derivative security
$32,100 $2.14 p/Share
15,000 Added 50.0%
15,000 Common Stock
Dec 01 2022
SELL
Open market or private sale
$270,000 $18.0 p/Share
15,000 Reduced 100.0%
0 Common Stock
Dec 01 2022
BUY
Exercise of conversion of derivative security
$32,100 $2.14 p/Share
15,000 Added 50.0%
15,000 Common Stock
Nov 01 2022
SELL
Open market or private sale
$20,241 $19.5 p/Share
1,038 Reduced 100.0%
0 Common Stock
TPN

Timothy P Noyes

CHIEF EXECUTIVE OFFICER
Boston, MA

Track Institutional and Insider Activities on AVTE

Follow Aerovate Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AVTE shares.

Notify only if

Insider Trading

Get notified when an Aerovate Therapeutics, Inc. insider buys or sells AVTE shares.

Notify only if

News

Receive news related to Aerovate Therapeutics, Inc.

Track Activities on AVTE